Tuesday, March 4, 2025
5:30 PM to 8:35 PM Eastern Time
Myeloma Rounds Durham
Hilton Durham near Duke University
Trinity Ballroom
3800 Hillsborough Road
Durham, North Carolina 27705
Self-parking is complimentary
*Only one (1) person per medical technology/pharmaceutical company may register and attend the Rounds. A corporate email address is required.
Agenda
5:30 PM – Dinner and Networking
6:30 PM – Welcome and Overview of Program
Cindy Varga, MD
6:35 PM – Overview of LLS Resources, including the Clinical Trial Support Center
Christen Hawthorne, RN, BSN, BMT-CN
6:40 PM – Updates in Multiple Myeloma Clinical Research
Eben Lichtman, MD
6:55 PM– Case Presentation on Bispecifics in the Community and Discussion*
Sendhilnathan (Hari) Ramalingam, MD and Cindy Varga, MD
7:25 PM – Case Presentation on High-risk Smoldering Multiple Myeloma and Discussion*
Kimberly Burcher, MD and Cristiana Costa Chase, DO
7:55 PM – Case Presentation on Maintenance Therapy in Transplant Eligible and Discussion*
John Mckay, DO and Sean Ormond, MD
8:25 PM – Discussion and Wrap-up
All Faculty
8:35 PM – Conclusion
Cindy Varga, MD
*Additional discussants: Drs. Gasparetto, Kang, and Voorhees
Description
Live interactive continuing medical education activity for healthcare professionals in Chapel Hill, Charlotte, Durham, Raleigh, Winston-Salem, and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloma.
Educational Objectives
After completing this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
-
Engage patients and caregivers in clinical trials discussions on newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
-
Explain disparities and challenges in diagnosis and treatment of myeloma
-
Apply evidence-based treatment strategies for optimal patient care
-
Identify patient education and support resources
Advisory Group
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Grace Elsey, PharmD, BCOP
Levine Cancer Institute
Atrium Health
Charlotte, NC
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forrest Baptist
Atrium Health
Winston-Salem, NC
Faculty
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Kimberly Burcher, MD
Duke University Hospital
Durham, NC
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Christen Hawthorne, RN, BSN, BMT-CN
The Leukemia & Lymphoma Society
Rye Brook, NY
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forrest Baptist
Atrium Health
Winston-Salem, NC
Sean Ormond, MD
Wake Forrest Baptist
Atrium Health
Winston-Salem, NC
Sendhilnathan (Hari) Ramalingam, MD
Duke Adult Blood and Marrow Transplant Clinic
Duke Cancer Center Raleigh
Durham, NC
Guest discussants: Cristina Gasparetto, MD, Yubin Kang, MD, and Peter Voorhees, MD
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
There is no commercial support associated with this activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: Profeducation@LLS.org.
